{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03905512: Phase 2 Interventional Completed Chronic Gout
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pasotuxizumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:indusatumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03830736: Not Applicable Interventional Completed Postprandial Glucose Regulation
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02325791: Phase 3 Interventional Completed Respiratory Syncytial Virus Infections
(2015)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04534725: Phase 3 Interventional Completed Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03040141: Phase 2 Interventional Completed Influenza A
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02134197: Phase 1 Interventional Terminated Neoplasms
(2014)
Source URL:
Class:
PROTEIN
